Authors


Lauren Buchanan

Latest:

FDA: Secukinumab Approved for Hidradenitis Suppurativa

Secukinumab is the only anti IL-17A inhibitor approved for hidradenitis suppurativa.


Caitlin McCafferty

Latest:

USDA provides conditional license for Canine Parvovirus Monoclonal Antibody

The brand-new treatment from Elanco is currently the only approved therapeutic solution proven to treat canine parvovirus.


Sam McAleese, M.D

Latest:

What's Next in Development of RSV Vaccines for Children?

How much progress have we made in developing therapies to treat this common childhood respiratory disorder?


Chris Ryan

Latest:

FDA Approves Drug Combo for Young Glioma Patients

A combination of dabrafenib with trametinib was approved by the FDA for treatment of pediatric patients 1 year and older with low-grade glioma & BRAF V600E mutation who require systemic therapy.


Ka Yeun Kim, BS, BPS, PharmD Candidate

Latest:

Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea

Evidence of the relationship between probiotics and antibiotics is lacking.


Sara Grossman, PharmD

Latest:

Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea

Evidence of the relationship between probiotics and antibiotics is lacking.


Mark Heinemeyer

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important


Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS

Latest:

The Wait for RSV Vaccines Continues

Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.



Katelyn Yamartino, PharmD

Latest:

Vericiguat (Verquvo) for Heart Failure With Reduced Ejection Fraction

A new drug review for vericiguat, indicated for heart failure, reports efficacy and safety data.


Joseph Burns

Latest:

Two Lawsuits Allege Iowa Medicaid Did Not Provide Proper Mental Health Care

Iowa's Department of Health and Human Services, which manages the two health insurers that delivered care to adults and children in the state’s Medicaid program last year, was alleged to provide inadequate mental and behavioral health care to children on Medicaid.


Yi Eun Park, BPS, PharmD Candidate

Latest:

Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea

Evidence of the relationship between probiotics and antibiotics is lacking.


Mishka Terplan, MD, MPH

Latest:

Assessing and Treating Opioid Use Disorder in Pregnancy

Opioid use disorder during pregnancy is stigmatized, but these patients deserve compassionate, nonjudgmental care.


Bruce Mueller, PharmD, FCCP, FASN, FNKF

Latest:

Misdosing: More Common Than You Think

Unfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.


Matthew Gavidia

Latest:

COVID-19 Omicron Variant Associated with Lower Risk of Severe Illness vs Delta Variant

Vaccination greatly reduces the probability of experiencing severe COVID-19 in both variants. Adults between the ages of 40 to 59 years saw the most significant reduction in risk when compared to individuals in other age categories.


Jaime Rosenberg

Latest:

Assessing Medicaid Policy Barriers to Gene, Cell Therapies

Researchers of a new paper discuss the inconsistencies between gene and cell therapy indications and payor coverage.


Ilya Petrou, MD

Latest:

The Chronic Complications For Children With T1DM

Part of the risk of developing kidney involvement begins when type 1 diabetes mellitus (T1DM) sets in and establishes itself in the patient, with up to 65% of children experiencing acute kidney injury during T1DM onset, which can further predispose to the development of future chronic kidney disease.


Darlene Dobkowski, MA

Latest:

Combining Keytruda And Chemo May Improve Survival in Advanced Endometrial Cancer

Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.


Margaret Emerson, DNP, APRN, PMHNP-BC

Latest:

Ethical, Practical Considerations of Exemptions to Employer Vaccine Mandates for Anxiety

Does anxiety justify an exemption from vaccine mandates among health care workers?


Rosanna Sutherby, PharmD

Latest:

Fertility Treatments Equally Effective in Women With, Without PCOS

Women with PCOS were more likely to begin fertility treatment with ovulation induction compared to those without PCOS.



Rachel Meyers, PharmD

Latest:

New Drug Approvals in Pediatrics

This past year has seen several important new drug approvals and labeling updates for children. Here is what you should know.


Patrick Campbell

Latest:

Advanced Hybrid Closed-Loop Technology Could Improve Quality of Life in Type 1 Diabetes

A 1-year observational follow-up of a 3-month randomized controlled trial provides insight into the benefits of advanced hybrid closed-loop system use in people with type 1 diabetes using multiple daily injections and self-monitoring of blood glucose.


Todd Shryock

Latest:

Many People Still Unaware Of Telehealth's Efficacy

Despite telehealth’s rise in popularity during the height of COVID-19, many individuals still aren't aware that it's a viable option.


Bernard Esquivel, MD, PhD, MHA, Chief Medical Officer, GenXys Health Care Systems

Latest:

Precision Prescribing Can Advance Mental Health Treatment

Pharmacogenetics can inform precision prescribing practices, which in turn can solve the inefficiencies of current prescribing models.


Hazel Billings-Chiu, PharmD candidate

Latest:

FDA Approves Oral Treatment for Postpartum Depression

Last August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.


Keith A. Reynolds

Latest:

Vaccine Update: FDA Approves Moderna COVID-19 Vaccine

Spikevax is now the second COVID-19 vaccine approved by regulators.


Tracy Nguyen, PharmD candidate

Latest:

Navigating Pediatric ADHD Medication Shortages

Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.


Lauren Massaro

Latest:

GLP-1s May Protect Against Cardiovascular Outcomes Regardless of Diabetes Status

Research presented at the Heart Failure Society of America 2024 Annual Meeting demonstrated that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduced cardiovascular events in patients without diabetes.


MHE Staff

Latest:

Oncology Drug Exkivity to be Voluntarily Withdrawn From US Market

Exkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.

© 2024 MJH Life Sciences

All rights reserved.